SCHEMBL158649

SCHEMBL158649

Cc1cc([NH])ccc1S(=O)(=O)O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.38
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
BRD4 O60885 2/20 0.37
ALDH1A1 P00352 3/20 0.36
MYC P01106 1/20 0.35
TP53 P04637 1/20 0.34
CREBBP Q92793 1/20 0.34
POLB P06746 2/20 0.33
RECQL P46063 2/20 0.33
SUMO2 P61956 1/20 0.33
SUMO1 P63165 1/20 0.33
SENP7 Q9BQF6 1/20 0.33
SENP3 Q9H4L4 1/20 0.33
SENP2 Q9HC62 1/20 0.33
SENP1 Q9P0U3 1/20 0.33
ESR2 Q92731 1/20 0.33
SMN1; SMN2 Q16637 3/20 0.33
GAA P10253 2/20 0.33
PKM P14618 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL156325 0.83 POLB (0.43) L3MBTL1MEN1KMT2ABRD4ALDH1A1
SCHEMBL1807015 0.79 PDIA6 (0.51) L3MBTL1MEN1KMT2ABRD4ALDH1A1
SCHEMBL1804216 0.79 L3MBTL1 (0.38) L3MBTL1MEN1KMT2ABRD4ALDH1A1
SCHEMBL10799138 0.78 TTR (0.31) SMN1; SMN2LMNAHPGDHIF1AHSD17B10
SCHEMBL30508542 0.78 ALDH1A1 (0.42) L3MBTL1MEN1KMT2ABRD4ALDH1A1
SCHEMBL29035724 0.78 ALDH1A1 (0.42) L3MBTL1MEN1KMT2ABRD4ALDH1A1
SCHEMBL29454656 0.78 MEP1B (0.49) L3MBTL1MEN1KMT2AALDH1A1TP53
SCHEMBL26645 0.78 MEP1B (0.49) L3MBTL1MEN1KMT2AALDH1A1TP53
SCHEMBL343257 0.78 L3MBTL1 (0.37) L3MBTL1ALDH1A1MYCSMN1; SMN2LMNA
SCHEMBL10262158 0.77 ALDH1A1 (0.44) L3MBTL1MEN1KMT2AALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0333656-A1 Reactive dyes, process for their preparation and their use CIBA-GEIGY AG (CH) 1989-09-20 EP claimed
US-8404036-B2 Water-soluble near-infrared absorbing coloring matters and aqueous inks containing same NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2013-03-26 US disclosed
US-20120056931-A1 MAGENTA COLORING MATTER, INK COMPOSITION, AND COLORED BODY NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2012-03-08 US disclosed
US-20110123784-A1 WATER-SOLUBLE NEAR-INFRARED ABSORBING COLORING MATTERS AND AQUEOUS INKS CONTAINING SAME NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2011-05-26 US disclosed
US-5118826-A Colorfastness CIBA-GEIGY CORPORATION (US) 1992-06-02 US disclosed
US-5021557-A Copper-containing formazan dye, colorfast blue shades on cellulose CIBA-GEIGY CORPORATION (US) 1991-06-04 US disclosed
EP-0327986-A2 Medicaments containing lactams, substituted lactams and process for their preparation Roche Diagnostics GmbH (DE) 1989-08-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110123784-A1 WATER-SOLUBLE NEAR-INFRARED ABSORBING COLORING MATTERS AND AQUEOUS INKS CONTAINING SAME IK, RB1, COL1A1 L3MBTL1 2085/4885MEN1 592/4885KMT2A 1224/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.